References
- 2014 ASCO. The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology. Available online at: www.asco.org/practice-research/cancer-care-america. Last accessed Jan. 13, 2016.
- 2014 Institute of Medicine. Ensuring Patient Access to Affordable Cancer Drugs: Workshop Summary. Available online at: www.iom.edu/Reports/2014/Ensuring-Patient-Access-to-Affordable-Cancer-Drugs.aspx. Last accessed Jan. 13, 2016.
- Benjamin L, et al. Impact of the healthcare payment system on patient access to oral anticancer drugs: An illustration from the French and United States contexts. BMC Health Serv Res. 2014;14(1):274.
- Fitch KV, et al. Parity for oral and intravenous/injected cancer drugs. Milliman Report; 2010. Available online at: www.milliman.com/uploadedFiles/insight/research/health-rr/parity-oral-intravenous-injected.pdf. Last accessed Jan. 13, 2016.
- Printz C. Drug parity legislation: States, organizations seek to make oral cancer drugs more affordable. Cancer. 2014;120(3):313–314.
- Wang B, et al. Chemotherapy parity laws: A remedy for high drug costs? JAMA Internal Medicine. 2014;174(11):1721–1722.
- 2013 IOM. Report Brief: Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Available online at: http://iom.nationalacademies.org/Reports/2013/%20Delivering-High-Quality-Cancer-Care-Charting-a-New-Course-for-a-System-in-Crisis.aspx. Last accessed Jan. 13, 2016.
- Zafar SY, Abernethy AP. Financial toxicity, part I: A new name for a growing problem. Oncol. 2013;27(2):80–81.
- Mancini R, et al. Oral oncolytics: Part 1—financial, adherence, and management challenges. Oncol. 2013;27(8):742–744, 824.
- 2013 ASCO. ASCO Endorses Legislation Providing Parity to Cancer Drugs. Available online at: asco.org/advocacy/asco-endorses-legislation-providing-parity-cancer-drugs. Last accessed Jan. 13, 2016.
- Conti RM, et al. National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011. Health Affairs. 2015;33(10):1721–1727.
- Faiman B. Oral cancer therapy: Policy implications for the uninsured and underinsured populations. J Adv Pract Oncol. 2013;4(5):354–360.
- 2015 PEAC. (2015). Oral Chemotherapy Access Legislative Landscape Map: October 2015. Available online at: peac.myeloma.org/oral-chemo-access-map. Last accessed Jan. 13, 2016.
- Congress.gov. (2015a). H.R.2739 Cancer Drug Coverage Parity Act of 2015, U.S. House of Representatives, 114th Congress (2015-2016). Available online at: congress.gov/bill/114th-congress/house-bill/2739. Last accessed Jan. 13, 2016.
- Congress.gov. (2015b). S. 1566 Cancer Drug Coverage Parity Act of 2015, U.S. Senate, 114th Congress (2015–2016). Available online at: congress.gov/bill/114th-congress/senate-bill/1566. Last accessed Jan. 13, 2016.
- Institute for Healthcare Improvement (IHI). (2015). The IHI Triple Aim Initiative. Available online at: ihi.org/Engage/Initiatives/TripleAim/pages/default.aspx. Last accessed Jan. 13, 2016.
- U.S. Department of Health and Human Services (U.S. DHHS). (2014). The Affordable Care Act: Section by Section. Available online at: www.hhs.gov/healthcare/rights/law/.
- Hutchins VA, et al. Analyzing the Affordable Care Act: Essential health benefits and implications for oncology. J Oncol Pract. 2013;9(2)73–77.
- Shih YC, et al. Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol. 2015;33(19):2190–2196.
- Mancini R, et al. Oral oncolytics: Part 2—legislation targeting cost and access, and other initiatives to reduce costs. Oncol. 2013;27(9):865–666, 871.
- Zafar SY, Abernethy AP. Financial toxicity, part II: How can we help with the burden of treatment-related costs? Oncol. 2013;27(4): 253–256.
- Kushnick HL. Pricing cancer drugs: When does pricing become profiteering? AMA J Ethics. 2015;17(8):750–753.
- Schwartz RN, et al. NCCN Task Force report: Specialty pharmacy. JNCCN. 2010;8(S4), S1–12.
- Lombardi C. Patient Adherence to Oral Cancer Therapies: A Nursing Resource Guide. Available online at: oncolink.org/resources/article.cfm?c=424&id=7058. Last accessed Jan. 13, 2016.
- Winkeljohn D. Adherence to oral cancer therapies. Clin J Oncol Nurs. 2010;14(4):461–466.
- Page MR (2015). Chemotherapy Parity Laws Ignore Cost, Quality Question. Oncology Live News. Available online at: www.onclive.com/publications/oncology-business-news/2014/December-2014/Chemotherapy-Parity-Laws-Ignore-Cost-Quality-Question#sthash.URxK3n8a.dpuf. Last accessed Jan. 13, 2016.
- Meropol NJ, et al. American Society of Clinical Oncology guidance statement: The cost of cancer care. J Clin Oncol. 2009;27(23):3868–3887.
- ACCC. Legislative Action Center: 2015 Cancer Polity Landscape. Available online at: www.accc-cancer.org/advocacy/LegislativeAction.asp. Last accessed Jan. 13, 2016.
- ONS. (2015). Position Statement: Access to Quality Cancer Care. Available online at: ons.org/advocacy-policy/positions/policy/access. Last accessed Jan. 13, 2016.